Surveys of transmitted HIV drug resistance in 7 geographic regions in China, 2008-2009

Clinical Infectious Diseases

Volumn 54, Issue SUPPL. 4, 2012, Pages

  Liao, Lingjie ^a   Xing, Hui ^a   Dong, Yonghui ^d   Qin, Guangming ^e   Ma, Yanling ^f   Lu, Hongyan ^b   Chen, Lin ^g   Zhang, Lan ^c   Osborne, Connie ^c   Seguy, Nicole ^c   Wei, Daying ^h   Sun, Feng ⁱ   Yang, Juan ^a   Ruan, Yuhua ^a   Shao, Yiming ^a  

^a CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^b CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

^d Xinjiang Center for Disease Control and Prevention   (China)

^e SICHUAN CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^f YUNNAN PROVINCIAL CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^g SHENZHEN CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^h Liangshan Center for Disease Control and Prevention   (China)

ⁱ Yili Center for Disease Control and Prevention   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DIDANOSINE; EFAVIRENZ; LOPINAVIR; NEVIRAPINE; STAVUDINE; TENOFOVIR; ZIDOVUDINE;

CHINA; DISEASE CLASSIFICATION; GOVERNMENT; HEALTH SURVEY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; PATIENT GUIDANCE; PRIORITY JOURNAL; REVIEW; VIRUS TRANSMISSION; WORLD HEALTH ORGANIZATION;

ANTI-RETROVIRAL AGENTS; CHINA; DRUG RESISTANCE, VIRAL; HIV INFECTIONS; HUMANS; POPULATION SURVEILLANCE;

EID: 84860388306     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cir1016     Document Type: Review

References (11)

1. Ministry of Health, People's Republic of China, Joint United Nations Programme on HIV/AIDS, World Health Organization. 2009 estimates for the HIV/AIDS epidemic in China. Beijing, China: National Center for AIDS/STD Prevention and Control, China CDC, 2010.
2. Zhang F, Dou Z, Yu L, et al. The effect of highly active antiretroviral therapy on mortality among HIV-infected former plasma donors in China. Clin Infect Dis 2008; 47:825-33.
3. Bennett DE, Myatt M, Bertagnolio S, Sutherland D, Gilks CF. Recommendations for surveillance of transmitted HIV drug resistance in countries scaling up antiretroviral treatment. Antivir Ther 2008; 13(Suppl 2):25-36. (Pubitemid 352019087)
4. Myatt M, Bennett DE. A novel sequential sampling technique for the surveillance of transmitted HIV drug resistance by cross-sectional survey for use in low resource settings. Antivir Ther 2008; 13(Suppl 2):37-48. (Pubitemid 352019088)
5. Chinese Center for Disease Control and Prevention. National guideline for detection of HIV/AIDS. Beijing, China: National Center for AIDS/STD Prevention and Control, China CDC, 2009.
6. Zhong P, Pan Q, Ning Z, et al. Genetic diversity and drug resistance of human immunodeficiency virus type 1 (HIV-1) strains circulating in Shanghai. AIDS Res Hum Retroviruses 2007; 23:847-56. (Pubitemid 47267490)
7. Gifford RJ, Liu TF, Rhee SY, et al. The calibrated population resistance tool: standardized genotypic estimation of transmitted HIV-1 drug resistance. Bioinformatics 2009; 25:1197-8.
8. Bennett DE, Camacho RJ, Otelea D, et al. Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update. PLoS One 2009; 4:e4724.
9. Lole KS, Bollinger RC, Paranjape RS, et al. Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination. J Virol 1999; 73:152-60. (Pubitemid 28565356)
10. Zhang J, Kang D, Fu J, et al. Surveillance of transmitted HIV type 1 drug resistance in newly diagnosed HIV type 1-infected patients in Shandong Province, China. AIDS ResHum Retroviruses 2010; 26:99-103.
11. Liu TF, Shafer RW. Web resources for HIV type 1 genotypic-resistance test interpretation. Clin Infect Dis 2006; 42:1608-18.